Denmark's Novozymes has renewed and extended its collaboration with
UK-based biotech Upperton Limited on a drug delivery system that
exploits the natural binding properties of recombinant protein
nanoparticles to improve compound...
Midatech, the UK group exploring the therapeutic and diagnostic
applications of nanoparticles as drug delivery vehicles, scaffolds
for synthetic vaccines or antibiotics and non-invasive imaging
agents, is hoping to put its first product...
A recently-launched project by the European Union is aiming to
demonstrate once and for all whether nanoparticles - which underpin
the emerging discipline of nanotechnology - are safe, reports